Today: 19 May 2026
Macquarie Group share price slips as new director filing lands, RBA decision looms
2 February 2026
1 min read

Macquarie Group share price slips as new director filing lands, RBA decision looms

Sydney, Feb 2, 2026, 17:19 AEDT — Market closed

  • Macquarie shares slipped 0.19%, ending the day at A$211.77
  • Filing reveals William Vereker, the newly appointed director, did not hold any Macquarie securities when he took up the role
  • Traders are turning their attention to Tuesday’s RBA decision and Macquarie’s operational briefing scheduled for next week

Macquarie Group (MQG.AX) shares edged down 0.19% Monday, finishing at A$211.77. The stock kicked off the day at A$213, with intraday moves ranging from A$210.35 to A$214.48. A director’s interest notice lodged with the Australian Securities Exchange revealed that newly appointed independent director William Vereker did not hold any Macquarie securities when he joined.

The modest move unfolded amid a broader risk-off mood, with the S&P/ASX 200 slipping 1.02% as materials, metals, and gold shares dropped.

Overnight jitters weighed heavily. Silver tumbled as much as 10% following Friday’s sharp drop, while gold dipped over 4% in volatile trading after CME Group hiked margin requirements — the collateral traders must hold on leveraged futures. Reuters noted markets now price in roughly a 75% chance the Reserve Bank of Australia will raise rates by 25 basis points to 3.85% this week. “We think this is a buying opportunity for both gold and silver,” said Vivek Dhar, mining and commodities strategist at Commonwealth Bank of Australia. Reuters

Vereker’s notice, submitted as an Appendix 3X, follows ASX listing rules requiring disclosure of a director’s relevant securities interests. The company confirmed his appointment took effect on Feb. 1.

Macquarie, a diversified financial services firm, runs operations across asset management, banking, and markets, with a notable presence in commodities trading. Its divisions include Macquarie Asset Management, Banking and Financial Services, Commodities and Global Markets, and Macquarie Capital.

The RBA will reveal its policy decision Tuesday at 2:30 p.m. AEDT, followed by a media briefing an hour later. Simultaneously, it releases its quarterly Statement on Monetary Policy.

For Macquarie investors, the coming days hinge on rates and risk appetite: how funding costs evolve and if markets settle enough to boost deal flow and client activity.

Macquarie has brought in Perella Weinberg Partners to jumpstart the sale of KCom, the Hull-based broadband provider, The Times reports. This move comes after lenders like NatWest and Lloyds Banking Group pushed for action. The paper notes the sale price would probably be significantly below the £627 million paid in 2019.

The director notice is standard procedure. The bigger immediate risk lies in a rate surprise from the RBA—whether that’s the size of the hike or a shift in tone—especially as commodity markets keep fluctuating sharply.

Traders are now turning to Tuesday’s RBA decision. Macquarie will host its 2026 operational briefing on Feb. 10 at 10:00 a.m. AEDT.

Stock Market Today

  • TSMC Stock Surges as Nvidia Q1 Earnings Loom, Foundry Partner Leads AI Chip Market
    May 19, 2026, 5:26 AM EDT. Nvidia (NASDAQ: NVDA) will report its fiscal 2027 Q1 results on May 20 amid keen investor focus on the AI sector. Nvidia shares have lagged, gaining 21% over six months compared to a 73% surge in the semiconductor index. Taiwan Semiconductor Manufacturing (TSMC) (NYSE: TSM), Nvidia's leading chip foundry partner, has outperformed with a 33% rise in 2026. TSMC dominates 72% of the pure-play foundry market and 38% of the broader Foundry 2.0 segment, which integrates advanced packaging and testing crucial for AI chip production. The Foundry 2.0 market expanded 16% in 2025 to $320 billion, with TSMC achieving 36% revenue growth. Analysts see TSMC well-positioned for continued growth as AI demand increases, potentially benefiting post-Nvidia earnings.

Latest articles

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

GeoVax Stock Rockets Nearly 80% as Tiny Vaccine Developer Grabs Biodefense Spotlight

19 May 2026
GeoVax Labs shares surged nearly 80% to $2.21 Monday after announcing a $3 million private placement amid heightened interest in biodefense following a WHO emergency alert over Ebola in Africa. The company does not sell an approved Ebola vaccine; its lead candidate targets mpox and smallpox. GeoVax reported $1.3 million in cash at March 31 and a quarterly net loss of $5.3 million. The new funding is expected to close around May 19.
Evolution stock jumps on €2 billion move

Evolution stock jumps on €2 billion move

19 May 2026
Evolution AB shares surged 9% in Stockholm after the company announced a €2 billion share buyback, one of Sweden’s largest. The buyback starts immediately and may run until the 2027 annual meeting, capped at 10% of shares. The OMXS30 index rose just 0.75% in comparison. Evolution also secured a €300 million revolving credit facility from J.P. Morgan SE and Citibank Europe.
NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

NextEra shares dip after $66.8B Dominion deal—What’s on traders’ radar now

19 May 2026
NextEra Energy shares fell 4.6% to $89.04 late Monday after announcing a $66.8 billion stock-led merger with Dominion Energy, whose shares rose 9.4% to $67.56. The deal would create one of the world’s largest electric utilities, serving about 10 million customer accounts and owning 110 gigawatts of generation across four states.

Popular

Regeneron stock sinks after cancer trial miss prompts selloff

Regeneron stock sinks after cancer trial miss prompts selloff

19 May 2026
Regeneron Pharmaceuticals shares fell 9.8% to $629.68 Monday after its late-stage melanoma drug trial with fianlimab failed to meet the main goal. The study did not show a statistically significant benefit over Merck’s Keytruda. At least 10 brokerages cut price targets. The decline outpaced broader market losses, with the Nasdaq down 0.5%.
Telstra share price bucks ASX slide as miners sink; RBA call and Feb results loom
Previous Story

Telstra share price bucks ASX slide as miners sink; RBA call and Feb results loom

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency
Next Story

ST Engineering share price slips after NeuSAR-2 satellite plan and Singapore’s new space agency

Go toTop